Ledger.Open graph →
SEC Form D · filed October 22, 2013

Sorrento Therapeutics, Inc

Offering
$1.9M
Sold
$1.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Kim D. Janda · San Diego, CADirectorDavid Webb · San Diego, CADirectorHenry Ji · San Diego, CAExec · DirectorRichard G. Vincent · San Diego, CAExecCam Gallagher · San Diego, CADirectorJaisim Shah · West Conshohocken, PADirectorRonald H. Flower · Dallas, TXExec · DirectorDavid W. Jaffin · New York, NYExecTommy G. Thompson · New York, NYDirectorThomas J. Carroll · Newark, NJDirectorMichael J. Doyle · Boston, MADirectorEmst-Gunter Afting · San Diego, CADirectorScott M. Salka · San Diego, CADirectorVoung Dr. Trieu · San Diego, CAExec · DirectorGeorge Uy · San Diego, CAExecJaisim Shah · Warren, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗